Goodwin Procter advised Cathay Health on the deal.TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has closed a Series C round of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now